MyoD synergizes with the E-protein HEBβ to induce myogenic differentiation

Molecular and Cellular Biology

Volumn 26, Issue 15, 2006, Pages 5771-5783

  Parker, Maura H ^a,b,c   Perry, Robert L S ^b,e   Fauteux, Mélanie C ^a   Berkes, Charlotte A ^c   Rudnicki, Michael A ^a,b,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF OTTAWA   (Canada)

^e YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC PROTEIN; E PROTEIN; HELIX LOOP HELIX PROTEIN; HETERODIMER; ISOPROTEIN; MYOD PROTEIN; MYOGENIN; PROTEIN; PROTEIN HEB; PROTEIN HEB ALPHA; PROTEIN HEB BETA; PROTEIN SUBUNIT; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; E BOX ELEMENT; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; KNOCKOUT GENE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; SKELETAL MUSCLE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; MAP KINASE KINASE 1; MICE; MUSCLE, SKELETAL; MYOBLASTS; MYOD PROTEIN; MYOGENIN; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN ISOFORMS; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 33746538915     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02404-05     Document Type: Article

References (62)

1. Asakura, A., A. Fujisawa-Sehara, T. Komiya, and Y. Nabeshima. 1993. MyoD and myogenin act on the chicken myosin light-chain 1 gene as distinct transcriptional factors. Mol. Cell. Biol. 13:7153-7162.
2. Ballinger, C. A., P. Connell, Y. Wu, Z. Hu, L. J. Thompson, L. Y. Yin, and C. Patterson. 1999. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol. Cell. Biol. 19:4535-4545.
3. Bergstrom, D. A., B. H. Penn, A. Strand, R. L. Perry, M. A. Rudnicki, and S. J. Tapscott. 2002. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9:587-600.
4. Bergstrom, D. A., and S. J. Tapscott. 2001. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family. Mol. Cell. Biol. 21:2404-2412.
5. Berkes, C. A., D. A. Bergstrom, B. H. Penn, K. J. Seaver, P. S. Knoepfler, and S. J. Tapscott. 2004. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol. Cell 14:465-477.
6. Black, B. L., J. D. Molkentin, and E. N. Olson. 1998. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol. Cell. Biol. 18:69-77.
7. Bour, B. A., M. A. O'Brien, W. L. Lockwood, E. S. Goldstein, R. Bodmer, P. H. Taghert, S. M. Abmayr, and H. T. Nguyen. 1995. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes Dev. 9:730-741.
8. Cao, Y., R. M. Kumar, B. H. Penn, C. A. Berkes, C. Kooperberg, L. A. Boyer, R. A. Young, and S. J. Tapscott. 2006. Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO J. 25:502-511.
9. Conway, K., C. Pin, J. A. Kiernan, and P. Merrifield. 2004. The E-protein HEB is preferentially expressed in developing muscle. Differentiation 72:327-340.
10. Coolican, S. A., D. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653-6662.
11. Corbeil, H. B., P. Whyte, and P. E. Branton. 1995. Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 11:909-920.
12. Davis, R. L., P. F. Cheng, A, B. Lassar, and H. Weintraub. 1990. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 60:733-746.
13. Davis, R. L., H. Weintraub, and A. B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51:987-1000.
14. Donoghue, M., H. Ernst, B. Wentworth, B. Nadal-Ginard, and N. Rosenthal. 1988. A muscle-specific enhancer is located at the 3′ end of the myosin light-chain 1/3 gene locus. Genes Dev. 2:1779-1790.
15. Gerber, A. N., T. R. Klesert, D. A. Bergstrom, and S. J. Tapscott. 1997. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 11:436-450.
16. Gill, R. M., and P. A. Hamel. 2000. Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle. J. Cell Biol. 148:1187-1201.
17. Giorgino, F., O. de Robertis, L. Laviola, C. Montrone, S. Perrini, K. C. McCowen, and R. J. Smith. 2000. The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. Proc. Natl. Acad. Sci. USA 97:1125-1130.
18. Goldfarb, A. N., K. Lewandowska, and C. A. Pennell. 1998. Identification of a highly conserved module in E proteins required for in vivo helix-loop-helix dimerization. J. Biol. Chem. 273:2866-2873.
19. Golebiowski, F., A. Szulc, M. Sakowicz, A. Szutowicz, and T. Pawelczyk. 2003. Expression level of Ubc9 protein in rat tissues. Acta Biochim. Pol. 50:1065-1073.
20. Guo, K., and K. Walsh. 1997. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J. Biol. Chem. 272:791-797.
21. Hu, J. S., E. N. Olson, and R. E. Kingston. 1992. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol. Cell. Biol. 12:1031-1042.
22. Huang, Z., L. Nie, M. Xu, and X. H. Sun. 2004. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination. Mol. Cell. Biol. 24:8951-8962.
23. Huggins, G. S., M. T. Chin, N. E. Sibinga, S. L. Lee, E. Haber, and M. E. Lee. 1999. Characterization of the mUBC9-binding sites required for E2A protein degradation. J. Biol. Chem. 274:28690-28696.
24. Kassar-Duchossoy, L., B. Gayraud-Morel, D. Gomes, D. Rocancourt, M. Buckingham, V. Shinin, and S. Tajbakhsh. 2004. Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature 431:466-471.
25. Kho, C. J., G. S. Huggins, W. O. Endege, C. M. Hsieh, M. E. Lee, and E. Haber. 1997. Degradation of E2A proteins through a ubiquitin-conjugating enzyme, UbcE2A. J. Biol. Chem. 272:3845-3851.
26. Kislinger, T., A. O. Gramolini, Y. Pan, K. Rahman, D. H. Maclennan, and A. Emili. 2005. Proteome dynamics during C2C12 myoblast differentiation. Mol. Cell Proteomics 4:887-901.
27. Klein, E. S., D. M. Simmons, L. W. Swanson, and M. G. Rosenfeld. 1993. Tissue-specific RNA splicing generates an ankyrin-like domain that affects the dimerization and DNA-hinding properties of a bHLH protein. Genes Dev. 7:55-71.
28. Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintrauh. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66:305-315.
29. Liu, D., B. L. Black, and R. Derynck. 2001. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15:2950-2966.
30. Loveys, D.A., M. B. Streiff, T. S. Schaefer, and G. J. Kato. 1997. The mUBC9 murine ubiquitin conjugating enzyme interacts with the E2A transcription factors. Gene 201:169-177.
31. Mandolesi, G., S. Gargano, M. Pennuto, B. Illi, R. Molfetta, L. Soucek, L. Mosca, A Levi, R. Jucker, and S. Nasi. 2002. NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction. FEBS Lett. 510:50-56.
32. Markus, M., Z. Du, and R. Benezra. 2002. Enhancer-specific modulation of E protein activity. J. Biol. Chem. 277:6469-6477.
33. Massari, M. E., P. A. Grant, M. G. Pray-Grant, S. L. Berger, J. L. Workman, and C. Murre. 1999. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell 4:63-73.
34. Murre, C., P. S. McCaw, H. Vaessin, M. Caudy, L. Y. Jan, Y. N. Jan, C. V. Cabrera, J. N. Buskin, S. D. Hauschka, A. B. Lassar, et al. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 58:537-544.
35. Murre, C., A. Voronova, and D. Baltimore. 1991. B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol. Cell. Biol. 11:1156-1160.
36. Naya, F. S., and E. Olson. 1999. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11:683-688.
37. Neuman, T., A. Keen, E. Knapik, D. Shain, M. Ross, H. O. Nornes, and M. X. Zuber. 1993. ME1 and GE1: basic helix-loop-helix transcription factors expressed at high levels in the developing nervous system and in morphogenetically active regions. Eur. J. Neurosci. 5:311-318.
38. Nie, L., M. Xu, A. Vladimirova, and X. H. Sun. 2003. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J. 22:5780-5792.
39. Novitch, B. G., D. B. Spicer, P. S. Kim, W. L. Cheung, and A. B. Lassar. 1999. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9:449-459.
40. Ornatsky, O. I., J. J. Andreucei, and J. C. McDermott. 1997. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 272:33271-33278.
41. Parker, M. H., P. Seale, and M. A. Rudnicki. 2003. Looking back to the embryo: defining transcriptional networks in adult myogencsis. Nat. Rev. Genet. 4:497-507.
42. Penn, B. H., D. A. Bergstrom, F. J. Dilworth, E. Bengal, and S. J. Tapscott. 2004. A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. Genes Dev. 18:2348-2353.
43. Perry, R. L., M. H. Parker, and M. A. Rudnicki. 2001. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell 8:291-301.
44. Ridgeway, A. G., S. Wilton, and I. S. Skerjanc. 2000. Myocyte enhancer factor 2C and myogenin up-regulate each other's expression and induce the development of skeletal muscle in PI9 cells. J. Biol. Chem. 275:41-46.
45. Rose, S. D., G. H. Swift, M. J. Peyton, R. E. Hammer, and R. J. MacDonald. 2001. The role of PTF1-P48 in pancreatic acinar gene expression. J. Biol. Chem. 276:44018-44026.
46. Sabourin, L. A., A. Girgis-Gabardo, P. Seale, A. Asukura, and M. A. Rudnicki. 1999. Reduced differentiation potential of primary MyoD-/- myogcnic cells derived from adult skeletal muscle. J. Cell Biol. 144:631-643.
47. Shin, E. K., A. Shin, C. Paulding, B. Schaffhausen, and A. S. Yee. 1995. Multiple change in E2F function and regulation occur upon muscle differentiation. Mol. Cell. Biol. 15:2252-2262.
48. Tamir, Y., and E. Bengal. 2000. Phosphoinositide 3-kinase induces the transcriptional activity of MEF2 proteins during muscle differentiation. J. Biol. Chem. 275:34424-34432.
49. Tapscott, S. J., R. L. Davis, M. J. Thayer, P. F. Cheng, H. Weintraub, and A. B. Lassar. 1988. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242:405-411.
50. Uittenbngaard, M., D. L. Martinka, and A. Chiaramello. 2003. The basic helix-loop-helix differentiation factor Nex1/MATH-2 functions as a key activator of the GAP-43 gene. J. Neurochem. 84:678-688.
51. Wang, D. Z., M. R. Valdez, J. McAnally, J. Richardson, and E. N. Olson. 2001. The Mef2c gene is a direct transcriptional target of myogenic hHLH and MEF2 proteins during skeletal muscle development. Development 128:4623-4633.
52. Wang, J., K. Helin, P. Jin, and B. Nadal-Ginard. 1995. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1. Cell Growth Differ. 6:1299-1306.
53. Wang, J., Q. Huang, W. Tang, and B. Nadal-Ginard. 1996. E2F1 inhibition of transcription activation by myogenic basic helix-loop-helix regulators. J. Cell. Biochem. 62:405-410.
54. Watanabe, Y., K. Kawakami, Y. Hirayama, and K. Nagano. 1993. Transcription factors positively and negatively regulating the Na,K-ATPase alpha 1 subunit gene. J. Biochem. (Tokyo) 114:849-855.
55. Weintraub, H., R. Davis, D. Lockshon, and A. Lassar. 1990. MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc. Natl. Acad. Sci. USA 87:5623-5627.
56. Weintranb, H., V. J. Dwarki, I. Verma, R. Davis, S. Hollenberg, L. Snider, A. Lassar, and S. J. Tapscott. 1991. Muscle-specific transcriptional activation by MyoD. Genes Dcv. 5:1377-1386.
57. Westerman, B. A., C. Murre, and C. B. Oudejans. 2003. The cellular Pax-Hox-helix connection. Biochim. Biophys. Acta 1629:1-7.
58. Wilson, E. M., J. Tureckova, and P. Rotwein. 2004. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation. Mol. Biol. Cell 15:497-505.
59. Xu, Q., and Z. Wu. 2000. The insulin-like growth factor- phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J. Biol. Chem. 275:36750-36757.
60. Zetser, A., E. Gredinger, and E. Bengal. 1999. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mcf2c transcription factor. J. Biol. Chem. 274:5193-5200.
61. Zhuang, Y., P. Cheng, and H. Weintraub. 1996. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16:2898-2905.
62. Zhuang, Y., C. G. Kim, S. Bartelmez, P. Cheng, M. Groudine, and H. Weintraub. 1992. Helix-loop-helix transcription factors E12 and E47 are not essential for skeletal or cardiac myogenesis, erythropoiesis, chondrogenesis, or neurogenesis. Proc. Natl. Acad. Sci. USA 89:12132-12136.